Hyperfine Inc
NASDAQ:HYPR
Hyperfine Inc
Revenue
Hyperfine Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
Hyperfine Inc
NASDAQ:HYPR
|
Revenue
$11m
|
CAGR 3-Years
235%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is Hyperfine Inc's Revenue?
Revenue
11m
USD
Based on the financial report for Dec 31, 2023, Hyperfine Inc's Revenue amounts to 11m USD.
What is Hyperfine Inc's Revenue growth rate?
Revenue CAGR 3Y
235%
Over the last year, the Revenue growth was 62%. The average annual Revenue growth rates for Hyperfine Inc have been 235% over the past three years .